A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects. [electronic resource]
- Bulletin of the World Health Organization 1985
- 611-5 p. digital
Adult Brazil Double-Blind Method Drug Combinations--therapeutic use Drug Evaluation Humans Malaria--drug therapy Male Mefloquine Plasmodium falciparum Pyrimethamine--therapeutic use Quinolines--therapeutic use Random Allocation Sulfadoxine--therapeutic use Sulfanilamides--therapeutic use